BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16088195)

  • 1. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia.
    Uzun H; Benian A; Madazli R; Topçuoğlu MA; Aydin S; Albayrak M
    Gynecol Obstet Invest; 2005; 60(4):195-200. PubMed ID: 16088195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of oxidative stress markers in first trimester for assessment of preeclampsia risk.
    Genc H; Uzun H; Benian A; Simsek G; Gelisgen R; Madazli R; Güralp O
    Arch Gynecol Obstet; 2011 Dec; 284(6):1367-73. PubMed ID: 21344259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in white coat hypertension; role of paraoxonase.
    Uzun H; Karter Y; Aydin S; Curgunlu A; Simşek G; Yücel R; Vehiyd S; Ertürk N; Kutlu A; Benian A; Yaldiran A; Oztürk E; Erdine S
    J Hum Hypertens; 2004 Jul; 18(7):523-8. PubMed ID: 14985779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia.
    Kim YJ; Park H; Lee HY; Ahn YM; Ha EH; Suh SH; Pang MG
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):47-52. PubMed ID: 16949193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus.
    Sozer V; Himmetoglu S; Korkmaz GG; Kaya S; Aydin S; Yumuk V; Hatemi H; Uzun H
    Minerva Med; 2014 Jun; 105(3):237-44. PubMed ID: 24988089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
    Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
    Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship among plasma secretory phospholipase A2, oxidized low density lipoprotein & paraoxonase activities in hypertensive subjects treated with angiotensin converting enzyme inhibitors.
    Konukoglu D; Firtina S; Serin O; Cavusoglu C
    Indian J Med Res; 2009 Apr; 129(4):390-4. PubMed ID: 19535833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia.
    Sarandöl E; Safak O; Dirican M; Uncu G
    Clin Biochem; 2004 Nov; 37(11):990-6. PubMed ID: 15498527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction.
    Bayram F; Kocer D; Ozsan M; Muhtaroglu S
    Gynecol Endocrinol; 2012 Jul; 28(7):497-501. PubMed ID: 22703625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
    Serin O; Konukoglu D; Firtina S; Mavis O
    Horm Metab Res; 2007 Mar; 39(3):207-11. PubMed ID: 17373636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low plasma levels of oxidized low density lipoprotein in preeclampsia.
    Raijmakers MT; van Tits BJ; Hak-Lemmers HL; Roes EM; Steegers EA; Peters WH
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1173-7. PubMed ID: 15548151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis.
    Sattar N; Bendomir A; Berry C; Shepherd J; Greer IA; Packard CJ
    Obstet Gynecol; 1997 Mar; 89(3):403-8. PubMed ID: 9052594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
    Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z
    Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of maternal and foetal serum lipid profile and placental oxidised low density lipoprotein accumulation in preeclampsia and normotensive pregnancies].
    Pecks U; Caspers R; Sosnowsky K; Freerksen N; Maass N; Huppertz B; Rath W
    Z Geburtshilfe Neonatol; 2012 Oct; 216(5):220-5. PubMed ID: 23108966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia.
    Yaghmaei M; Hashemi M; Azarian A; Moazeni-Roodi A; Mokhtari M; Naghavai A; Salimi S; Mohammadi M; Taheri M; Ghavami S
    Arch Med Res; 2011 May; 42(4):324-8. PubMed ID: 21820612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control study of oxidized low density lipoproteins and preeclampsia risk.
    Sanchez SE; Williams MA; Muy-Rivera M; Qiu C; Vadachkoria S; Bazul V
    Gynecol Endocrinol; 2005 Oct; 21(4):193-9. PubMed ID: 16316839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
    Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S
    Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.